25/05/2026
74% of pharma companies struggle to scale AI value. And the failure patterns are consistent: scattered use case strategies, siloed business functions, broken data foundations, governance that can't keep pace.
We broke down the 8 reasons life sciences AI projects fail โ and what the companies getting it right are doing differently.
If you're building an AI strategy in pharma or biotech, this one's worth a read: https://ow.ly/oWMZ50Z3NhV